Preparation, In Vivo Administration, Dose-Limiting Toxicities, and Antineoplastic Activity of Cytochalasin B

An effective and inexpensive protocol for producing cytochalasins A and B is being disclosed to propose a viable method by which to examine the in vivo antineoplastic activity of these congeners in preclinical tumor-bearing mammalian models. In addition, we determine the maximum tolerated doses of c...

Descripción completa

Detalles Bibliográficos
Autores principales: Trendowski, Matthew, Zoino, Joseph N., Christen, Timothy D., Acquafondata, Christopher, Fondy, Thomas P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562975/
https://www.ncbi.nlm.nih.gov/pubmed/26310377
http://dx.doi.org/10.1016/j.tranon.2015.06.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562975/
https://www.ncbi.nlm.nih.gov/pubmed/26310377
http://dx.doi.org/10.1016/j.tranon.2015.06.003

Ejemplares similares